Doctor profile · Federal record
Dr. Vatsala Katragadda, MD
Internal Medicine Physician (CMS: Hematology/Oncology) · Specialist · Dearborn, MI
- NPI 1841270634
- Accepts Medicare
- 34 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
861 Monroe Street
Dearborn, MI 48124
(313) 274-1800
fax (313) 274-8717
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- July 11, 2018
- Year of graduation
- 1992 — 34 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Michigan #4301066984
- Medicaid
- MI #104623258
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841270634. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
852
Distinct HCPCS
4
Medicare allowed
$93,607
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 590 | 149 | $111 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 170 | 45 | $91 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 67 | 61 | $161 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 25 | 17 | $62 |
In context: peer comparison
Among 49 peers in this city , average services per provider: 96. This provider delivers 8.9× the peer median.Open Payments
Industry payments received
All-time total
$2,886
Transactions
78
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $975.14 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $236.46 | |
| PFIZER INC. | 11 | $230.28 | |
| AstraZeneca Pharmaceuticals LP | 10 | $221.06 | |
| Daiichi Sankyo Inc. | 7 | $154.99 | |
| Astellas Pharma US Inc | 4 | $101.79 | |
| Merck Sharp & Dohme LLC | 4 | $99.75 | |
| Ipsen Biopharmaceuticals, Inc | 3 | $83.99 | |
| Janssen Biotech, Inc. | 2 | $70.31 | |
| Mirati Therapeutics, Inc. | 2 | $51.96 | |
| Lilly USA, LLC | 2 | $49.39 | |
| Adaptive Biotechnologies Corporation | 2 | $48.27 | |
| Genentech USA, Inc. | 2 | $46.99 | |
| GlaxoSmithKline, LLC. | 2 | $45.15 | |
| PUMA BIOTECHNOLOGY, INC. | 2 | $39.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
37
Patients
0
Total drug cost
$351,673
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ibrance (Palbociclib) | Brand | 13 | 0 | $211,088 |
| Venclexta (Venetoclax) | Brand | 13 | 0 | $140,534 |
| Letrozole | Generic | 11 | 0 | $51 |
Hospital affiliations
Frequently asked questions
What is Dr. Vatsala Katragadda's medical specialty?
Dr. Vatsala Katragadda practices Internal Medicine Physician in Dearborn, MI.
Where does Dr. Vatsala Katragadda practice?
Dr. Vatsala Katragadda practices at 861 Monroe Street, Dearborn, MI 48124. Office phone: 3132741800.
What is Dr. Vatsala Katragadda's NPI?
Dr. Vatsala Katragadda's National Provider Identifier (NPI) is 1841270634, issued by NPPES.
Does Dr. Vatsala Katragadda accept Medicare assignment?
Yes. Dr. Vatsala Katragadda accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vatsala Katragadda commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99214); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.